Octapharma AG - logo

Octapharma AG - Company & Market Research Reports

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.


Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction [ITI]Therapy, Gene Therapy), And Segment Forecasts to 2024 - Product Thumbnail Image

Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction [ITI]Therapy, Gene Therapy), And Segment Forecasts to 2024

  • Report
  • 84 Pages
From
Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 42 Pages
From
Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 68 Pages
From
Global Markets and Manufacturing Technologies for Protein Drugs - Product Thumbnail Image

Global Markets and Manufacturing Technologies for Protein Drugs

  • Report
  • 176 Pages
From
Bleeding Disorders Treatment - Global Market Outlook (2017-2026) - Product Thumbnail Image

Bleeding Disorders Treatment - Global Market Outlook (2017-2026)

  • Report
  • 138 Pages
From
Bleeding Disorders Treatment Market - Global Forecast to 2021 - Product Thumbnail Image

Bleeding Disorders Treatment Market - Global Forecast to 2021

  • Report
  • 166 Pages
From
World Blood Plasma Derivatives Market - Opportunities and Forecasts, 2017 - 2023 - Product Thumbnail Image

World Blood Plasma Derivatives Market - Opportunities and Forecasts, 2017 - 2023

  • Report
From
Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players) - Product Thumbnail Image

Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)

  • Report
  • 155 Pages
From
Bleeding Disorders Treatment Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023 - Product Thumbnail Image

Bleeding Disorders Treatment Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • Report
  • 100 Pages
From
Global Blood Plasma Market: Industry Analysis & Outlook (2018-2022) - Product Thumbnail Image

Global Blood Plasma Market: Industry Analysis & Outlook (2018-2022)

  • Report
  • 91 Pages
From
Large Volume Wearable Injectors Market (3rd Edition), 2017-2027 - Product Thumbnail Image

Large Volume Wearable Injectors Market (3rd Edition), 2017-2027

  • Report
  • 365 Pages
From
Bolus Injectors Market, 2014 - 2024 - Product Thumbnail Image

Bolus Injectors Market, 2014 - 2024

  • Report
  • 179 Pages
From
Global Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy - Product Thumbnail Image

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

  • Report
  • 133 Pages
From
Global Recombinant Coagulation Factors Market Outlook: 2015-2020 - Product Thumbnail Image

Global Recombinant Coagulation Factors Market Outlook: 2015-2020

  • Report
  • 175 Pages
From
The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 46 Haemophilia Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 46 Haemophilia Patient Groups

  • Report
From
Global Factor VIII Deficiency Treatment Market 2017-2021 - Product Thumbnail Image

Global Factor VIII Deficiency Treatment Market 2017-2021

  • Report
  • 70 Pages
From
Global Hemophilia Drugs Market 2016-2020 - Product Thumbnail Image

Global Hemophilia Drugs Market 2016-2020

  • Report
  • 84 Pages
From
Global Human Albumin Market 2016-2020 - Product Thumbnail Image

Global Human Albumin Market 2016-2020

  • Report
  • 75 Pages
From
Global Hemophilia Therapeutics Market By Drug, By Type of Hemophilia, By Treatment, By Therapy Outlook 2022 - Product Thumbnail Image

Global Hemophilia Therapeutics Market By Drug, By Type of Hemophilia, By Treatment, By Therapy Outlook 2022

  • Report
  • 95 Pages
From
Loading Indicator
adroll